- Purpose of This Guideline
- Considerations and Contraindications
- COVID-19 Vaccine
- Haemophilus influenzae Type B (Hib)
- Hepatitis A Virus (HAV)
- Hepatitis B Virus (HBV)
- Human Papillomavirus (HPV)
- Influenza
- Measles, Mumps, Rubella (MMR)
- Meningococcal Serotypes A,C, W, and Y (MenACWY)
- Meningococcal Serotype B (MenB)
- Mpox
- Pneumococcal
- Tetanus, Diphtheria, and Pertussis (Tdap) and Tetanus-Diphtheria (Td)
- Varicella
- Zoster
- All Recommendations
- Guideline Information and Updates
The CDC considers people with HIV to be at risk of severe mpox disease and recommends prioritization of those at risk for receipt of the JYNNEOS mpox vaccine. Vaccination is used to prevent mpox and as postexposure prophylaxis; it protects against disease when administered before exposure. If administered after exposure, the vaccine may prevent development or decrease the severity of mpox disease. Go to Guidelines Program Recommendations
- Purpose and Goals of This Guideline
- HPV-Associated Cervical Disease
- HPV Prevention
- Cervical Cancer Prevention
- Screening for Cervical Abnormalities
- Screening for Cervical Dysplasia During Pregnancy
- Follow-Up of Abnormal Cervical Cytology Results
- Management of Cervical Cancer
- All Recommendations
- Guideline Information and Updates
Adopting a patient-centered sexual health framework when implementing Clinical Guidelines Program recommendations and guidance for clinical care of people with HIV and other STIs can improve patients’ overall health and well-being, reduce stigma, empower patients, and increase their uptake of sexual health–related resources. The patient-centered, HIV status–neutral approach to sexual health encouraged here promotes disease prevention and harm reduction and recognizes that there is much more to sexual health than disease prevention and treatment.
The purpose of this guidance is to inform NYS clinicians who provide primary care to adolescents about existing regulations that allow minors (<18 years old) to consent for and receive confidential HIV and STI screening and treatment and biomedical HIV prevention in the form of pre- or post-exposure prophylaxis (PrEP or PEP). Go to guidance | Download PDF
For guidance on healthcare for transgender and non-binary individuals, please consult the World Professional Association for Transgender Health (WPATH) Standards of Care Version 8 and/or the University of California San Francisco (UCSF) Center of Excellence for Transgender Health Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People.
- Introduction
- Linear Gingival Erythema (LGE)
- Necrotizing Ulcerative Gingivitis and Necrotizing Ulcerative Periodontitis (NUG/NUP)
- Necrotizing Ulcerative Stomatitis and Necrotizing Stomatitis (NUS/NS)
- Chronic Pre-Existing Periodontal Disease
- All Recommendations
- Appendix: Photo- and Radiographs of Periodontal Disease Associated with HIV
- Guideline Information and Updates
Oral health care is a critical component of comprehensive HIV medical management. Development of oral pathology is frequently associated with an underlying progression of HIV-disease status. A thorough soft-tissue examination may reveal pathology associated with dysphagia or odynophagia. Dental problems can result in or exacerbate nutritional problems. In addition, psychosocial and quality-of-life issues frequently are associated with the condition of the oral cavity and the dentition. See recommendations
- Insomnia Screening and Treatment
- HIV Infection in Older Adults
- Mental Health Screening
- Online Resources for Education, Information, and Services
- HIV Care Provider Definitions
- June 2016 Policy Statement: Defining Program Eligibility by HIV Status
- All FDA-Approved HIV Medications
- ARV Drug Name Abbreviation Key
- Mental Health Screening Tools
- GOALS Framework for Sexual History Taking in Primary Care
- Meningococcal Disease
- Health Equity Competencies for Health Care Providers